Biotech | Boulder, Colorado

SomaLogic Closes $121M Series A for Proteomics Platform Expansion

SomaLogic, provider of SomaScan, a leading proteomic  discovery platform helping to transform biomedical discovery and clinical diagnostics, closed a $121 million Series A led by Casdin Capital, with participation of Farallon Capital Management, Foresite Capital, Madryn Asset Management, and others. Eli Casdin, CIO and founder of Casdin Capital will join SomaLogic's Board of Directors. Proteomics is the study of proteomes-proteins produced by organisms and unstable proteins are often a sign or cause of disease. Funds will be used to improve, expand and commercialize SomaLogic’s world-leading proteomic products in both the clinical and life science markets. [Full story]